I appreciate your comments and respect your position.

New Post Public Reply Private Reply Replies (2) Message Board
joey68 snakeclaw #472
I appreciate your comments and respect your position. Seeing this board lacks in contributions (most people read and never post), it is nice to get some feedback.

First off, I understand what you are saying, but to begin, it is important to remember that I am not the spokesperson for Spectrascience. I'm simply an investor like everyone else. None of my posts are meant to be investment advice and quite often I mention no one should invest more than they can afford to lose. When you said, "however many of us are loosing our ass", it's important to remember that all investors, including you and me, have the ability to sell at any time. Continuing to remain invested in a company which you consider to be 'bleeding' and in a 'death spiral' may be a sign that this stock is not right for you. Something must be keeping you invested, right? If not, you would have sold long ago. By following the rule of not investing more than you can afford to lose, even if SCIE completely fails and we lose everything, it shouldn't affect us financially because we didn't invest more than we can afford to lose.

This is not to brag or anything, because I have no reason to try to impress random, online strangers: The majority of my posts (and I have over 200) in here have actual, physical DD with links, articles, government findings, research, human studies, etc etc. In my opinion, they all point towards success. Obviously SCIE could fail. Nothing is guaranteed in life. I said many times in previous posts that I would sell my entire SCIE position in a second if I believed this was going no where. But, to base it off of a chart... to sell simply because the price is lower today than it was yesterday..? That's not how I invest. I've been invested in countless stocks that I thought were going to succeed and then in the blink of an eye I sold because something didn't feel right. I'd do the same with SCIE if necessary.

You mentioned:
"i'm sure you can figure out a way to explain to us investors how this is a great investment no matter how low the pps gets"

My response to this is twofold:
First, I see SCIE as a great investment. It's up to you and everyone else to decide if they see SCIE as a great investment as well. Don't invest based on my posts (I say this in many of my posts and is also in my disclaimer below).

Second, I don't only post 'how great' SCIE is. Did you read my previous posts on how I hate SCIE's website for being out of date? They have 2014 articles on their front page. SCIE isn't perfect.

I also believe that perhaps you haven't read my previous posts (not that you have to, but they would clarify some of your concerns).

You said:
"the wavestat4 does work, and if it were really a god-send product i think the world would be clamoring for this device and yet it hasn't happened yet"

In a previous post, I posted (with a link) an article which explains why medical devices can take a decade or longer to go from rough draft to clinical usage. Why would the world clamor for the WavSTAT right now? The technology is brand new. Even being 10 years or more in the making, its still a new idea. When the first automobiles came out, it took years upon years upon years before people really figured out they were better than horse and carriage. People don't like change. Standard biopsies (cut it out and send it to the lab) is what we know. Our generation and our parents generation only knew of this biopsy and it is what makes us comfortable. It will take years before optical biopsies completely replace standard biopsies, but I believe it will happen.

In reference to VHS vs Betamax, you said, " it was better in every aspect" but this isn't actually true. One of the main reasons why VHS took the market away from Betamax was because VHS could record several hours while Betamax could only record one hour. And so, to use this argument in comparison to the WavSTAT, standard biopsies are like Betamax and optical biopsies are like VHS. Yes, two companies, Betamax had a product. But in the end, consumers wanted a tape that could record longer times and VHS won out. I see the same thing happening with the WavSTAT. Sure, standard biopsies work. But ultimately, optical biopsies are going to come out on top leaving standard biopsies in the dust.

In response to your comment, "is it possible there are other competing devices and technologies and that the wavestat4 isn't the only game in town?"..

Another previous post of mine listed all the competitors of the WavSTAT4. But SCIE holds many patents, and many of the competitors products cost thousands of more dollars compared to the WavSTAT.

You also mentioned:
" one of the light detection methods is spectroscopy, of which a company is already doing that in many countries. "

I'm not sure if you know this, but the WavSTAT 4 uses Laser Induced Fluorescence Spectroscopy . This IS the technology of the WavSTAT.

In conclusion, thanks for the post. It's always good to reevaluate my thinking and my investment decisions, but I'm still convinced the WavSTAT4 is at the forefront of it all. In the long run, even if it takes 3 more years to reach a penny, it wouldn't bother me because I'm a long. And until I find any article listing the WavSTAT4 doesn't work, i'll continue to remain invested. But of course, you do as you see fit for your own personal investment and don't invest based on this or any post.

Take care!

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 8

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 3

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 5

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 5

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 15

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 6

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 5

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 10

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 6

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into Data Breach at ConnectOnCall

Updated Category News Views 148

Investigation Launch into ConnectOnCall Data Breach Recently, FeganScott, a consumer-rights law firm, announced an investigation following a significant data breach at ConnectOnCall. This breach has potentially compromised the private information of over 900,000 providers and patients, raising serious concerns regarding data security in the healthcare sector. Details of...

Continue Reading
C-Suite Leaders Optimistic for 2025 Amidst Challenges

Updated Category News Views 311

C-Suite Leaders Prepare Optimistically for 2025 As we look towards 2025, a mix of optimism and uncertainty fills the air among U.S. C-suite executives. Recent findings from the 2025 Next Wave Survey, conducted by Altum Strategy Group along with YouGov, provide a revealing insight into the expectations and concerns of over 500 business leaders. This survey highlights how...

Continue Reading
Kalmar and MCT Partner to Enhance Sustainable Container Handling

Updated Category News Views 272

Kalmar and MCT Strengthen Sustainable Operations Kalmar Corporation has recently entered a noteworthy agreement with Medcenter Container Terminal (MCT) to deliver 20 eco-efficient hybrid straddle carriers. This significant order, recorded in the Q4 2024 order intake, is set for delivery during the first quarter of 2026. The Impact of Eco-Efficient Technology The hybrid...

Continue Reading
J.P. Morgan Initiates Stabilisation for Kommuninvest's Notes

Updated Category News Views 248

J.P. Morgan's Role in Stabilising Kommuninvest Notes In a significant move affecting the financial markets, J.P. Morgan SE has announced its role in the stabilisation of USD 1 billion worth of fixed-rate notes. These notes are issued by Kommuninvest i Sverige Aktiebolag (publ), a key player in the financial sector, particularly known for its focus on local government...

Continue Reading
Market Insights on GoDaddy Inc: Understanding Short Interest Dynamics

Updated Category News Views 109

Analyzing GoDaddy Inc's Market Sentiment GoDaddy Inc's (NYSE: GDDY) short interest has recently shown significant movement, dropping by 14.37% based on the latest figures. Currently, approximately 6.37 million shares have been sold short, representing 6.02% of the total available shares for public trading. This level of short interest reflects the current market sentiment...

Continue Reading